| Literature DB >> 29374771 |
S Klingberg1,2, K Mehlig3, V Sundh3,4, B L Heitmann5,6,7, L Lissner3.
Abstract
In women, a large hip circumference (HC) related to lower hip fracture risk, independent of age and regardless if HC was measured long before or closer to the fracture. In older women, body mass index (BMI) explained the protection.Entities:
Keywords: Body mass index; Hip circumference; Hip fractures; Longitudinal
Mesh:
Year: 2018 PMID: 29374771 PMCID: PMC5854726 DOI: 10.1007/s00198-017-4363-y
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Baseline and proximal characteristics by quintile of hip circumference in women in the PPSWG study
| Total sample | Quintile of hip circumference | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| Number of participants ( | |||||||
| Baseline | 1452 | 271 | 345 | 249 | 313 | 274 | |
| Proximal | 1326 | 268 | 239 | 289 | 285 | 245 | |
| Hip circumference (cm), range | |||||||
| Baseline | 79–136 | 79–93 | 94–97 | 98–100 | 101–105 | 106–136 | |
| Proximal | 74–145 | 74–93 | 94–97 | 98–102 | 103–108 | 109–145 | |
| Age (years), mean (SD) | |||||||
| Baseline | 47.6 (6.3) | 47.0 (6.2) | 47.2 (6.0) | 47.1 (5.9) | 48.5 (6.6) | 48.3 (6.4) | 0.005 |
| Proximal | 71.7 (10.9) | 70.5 (11.6) | 70.3 (11.5) | 72.8 (10.5) | 71.8 (10.5) | 72.9 (9.9) | 0.007 |
| Weight (kg), mean (SD) | |||||||
| Baseline | 64.5 (10.8) | 52.8 (5.0) | 59.5 (4.1) | 62.9 (4.2) | 68.3 (4.9) | 79.7 (10.6) | < 0.001 |
| Proximal | 67.2 (12.7) | 53.2 (6.0) | 60.9 (5.5) | 66.7 (6.4) | 72.1 (6.7) | 83.8 (12.4) | < 0.001 |
| Height (cm), mean (SD) | |||||||
| Baseline | 163.6 (5.9) | 161.6 (5.8) | 163.0 (5.6) | 163.5 (5.8) | 164.4 (5.6) | 165.5 (5.9) | < 0.001 |
| Proximal | 161.1 (6.2) | 159.3 (6.1) | 161.0 (5.6) | 161.8 (6.2) | 161.3 (6.3) | 161.9 (6.3) | < 0.001 |
| BMI (kg/m2), mean (SD) | |||||||
| Baseline | 24.1 (3.7) | 20.2 (1.8) | 22.4 (1.7) | 23.6 (1.8) | 25.3 (2.1) | 29.1 (3.7) | < 0.001 |
| Proximal | 25.9 (4.6) | 21.0 (2.4) | 23.5 (2.2) | 25.5 (2.2) | 27.7 (2.3) | 32.0 (4.3) | < 0.001 |
| Waist (cm), mean (SD) | |||||||
| Baseline | 73.8 (8.5) | 66.1 (4.5) | 70.4 (4.7) | 72.5 (4.9) | 76.3 (5.7) | 84.0 (9.6) | < 0.001 |
| Proximal | 84.9 (11.8) | 72.8 (7.0) | 78.6 (6.4) | 84.6 (7.7) | 89.4 (7.1) | 99.7 (9.6) | < 0.001 |
| Waist–hip ratio, mean (SD) | |||||||
| Baseline | 0.74 (0.05) | 0.73 (0.04) | 0.74 (0.05) | 0.73 (0.05) | 0.74 (0.05) | 0.75 (0.07) | < 0.001 |
| Proximal | 0.84 (0.07) | 0.81 (0.07) | 0.82 (0.07) | 0.85 (0.08) | 0.85 (0.07) | 0.86 (0.07) | < 0.001 |
| Education above basic level, | |||||||
| Baseline | 439 (30.3) | 94 (35.0) | 117 (34.0) | 84 (33.9) | 80 (25.6) | 64 (23.4) | 0.003 |
| Proximal | 405 (30.6) | 91 (34.1) | 80 (33.6) | 92 (31.8) | 73 (25.7) | 69 (28.2) | 0.16 |
| Smoker, | |||||||
| Baseline | 589 (40.6) | 156 (57.8) | 153 (44.5) | 100 (40.2) | 104 (33.2) | 76 (27.7) | < 0.001 |
| Proximal | 328 (24.8) | 96 (36.0) | 71 (29.7) | 66 (22.9) | 57 (20.1) | 38 (15.5) | < 0.001 |
| Sedentary, | |||||||
| Baseline | 265 (18.3) | 54 (19.9) | 59 (17.1) | 27 (10.8) | 70 (22.4) | 55 (20.1) | 0.007 |
| Proximal | 340 (25.6) | 68 (25.4) | 54 (22.6) | 61 (21.1) | 69 (24.2) | 88 (35.9) | 0.0011 |
| Ever use of HRTb, | |||||||
| Baseline | 56 (3.9) | 7 (2.6) | 20 (5.8) | 9 (3.6) | 13 (4.2) | 7 (2.6) | 0.20 |
| Proximal | 189 (14.3) | 44 (16.4) | 32 (13.4) | 36 (12.5) | 36 (12.6) | 41 (16.7) | 0.44 |
aP values across categories of hip circumference from analysis of variance (F test) for continuous variables and from χ2 test for categorical variables
bHRT hormone replacement therapy
Hazard ratios and 95% confidence intervals for the association between baseline hip circumference and hip fracture in Swedish women (n = 1452) (Prospective Population Study of Women in Gothenburg) and mutually adjusted covariates
| Number of cases | Covariate adjustment for | |||
|---|---|---|---|---|
| Age | + BMI and height | + physical activity, smoking, and HRT | ||
| Hip circumference (cm), quintiles: | ||||
| ≤ 93 | 54 | 1 (ref) | 1 (ref) | 1 (ref) |
| 94–97 | 72 | 0.88 (0.62–1.25) | 0.79 (0.53–1.19) | 0.85 (0.56–1.27) |
| 98–100 | 37 | 0.62 (0.40–0.93) | 0.53 (0.33–0.87) | 0.59 (0.36–0.96) |
| 101–105 | 49 | 0.65 (0.44–0.96) | 0.51 (0.30–0.86) | 0.57 (0.34–0.96) |
| ≥ 106 | 45 | 0.74 (0.50–1.10) | 0.49 (0.26–0.92) | 0.58 (0.31–1.10) |
| Age (years) | 257 | 1.13 (1.10–1.15) | 1.13 (1.11–1.16) | 1.14 (1.11–1.17) |
| BMI (kg/m2) | ||||
| < 20 | 31 | – | 0.98 (0.62–1.55) | 0.97 (0.61–1.54) |
| ≥ 20 to < 25 | 146 | – | 1 (ref) | 1 (ref) |
| ≥ 25 to < 30 | 61 | – | 1.19 (0.79–1.78) | 1.14 (0.76–1.72) |
| ≥ 30 | 19 | – | 1.48 (0.77–2.82) | 1.43 (0.75–2.74) |
| Height (cm) | 257 | – | 1.04 (1.02–1.07) | 1.04 (1.01–1.06) |
| LTPAa | 257 | – | – | 0.84 (0.61–1.16) |
| Smokingb | 257 | – | – | 1.59 (1.23–2.07) |
| HRT usec | 257 | – | – | 0.87 (0.45–1.70) |
aLTPA leisure time physical activity. Reference category = inactive
bReference category = non-smokers
cHRT hormone replacement therapy. Reference category = non-use
Hazard ratios and 95% confidence intervals for the association between proximal measure of hip circumference and hip fracture in Swedish women (n = 1326) (Prospective Population Study of Women in Gothenburg) and mutually adjusted covariates
| Number of cases | Covariate adjustment for | |||
|---|---|---|---|---|
| Age | + BMI and height | + Physical activity, smoking, and HRT | ||
| Hip circumference (cm), quintiles: | ||||
| ≤ 93 | 57 | 1 (ref) | 1 (ref) | 1 (ref) |
| 94–97 | 52 | 0.88 (0.60–1.28) | 0.94 (0.62–1.42) | 0.95 (0.63–1.45) |
| 98–102 | 45 | 0.59 (0.40–0.88) | 0.72 (0.45–1.16) | 0.75 (0.46–1.20) |
| 103–108 | 50 | 0.67 (0.46–0.99) | 0.98 (0.57–1.68) | 1.05 (0.61–1.80) |
| ≥ 109 | 28 | 0.43 (0.27–0.68) | 0.63 (0.31–1.27) | 0.67 (0.34–1.34) |
| Age (years) | 232 | 1.07 (1.05–1.09) | 1.08 (1.06–1.09) | 1.09 (1.07–1.10) |
| BMI (kg/m2) | ||||
| < 20.0 | 23 | – | 1.31 (0.80–2.16) | 1.30 (0.79–2.15) |
| ≥ 20.0 to < 25 | 113 | – | 1 (ref) | 1 (ref) |
| ≥ 25 to < 30 | 68 | – | 0.65 (0.44–0.97) | 0.66 (0.44–0.98) |
| ≥ 30 | 28 | – | 0.66 (0.35–1.23) | 0.68 (0.37–1.25) |
| Height (cm) | 232 | – | 1.03 (1.00–1.05) | 1.03 (1.00–1.05) |
| LTPAa | 232 | – | – | 1.10 (0.80–1.51) |
| Smokingb | 232 | – | – | 1.69 (1.23–2.32) |
| HRT usec | 232 | – | – | 0.85 (0.57–1.27) |
aLTPA leisure time physical activity. Reference category = inactive
bReference category = non-smokers
cHRT hormone replacement therapy. Reference category = non-use
Fig. 1Hazard ratio (HR) for proximal hip circumference in relation to risk of hip fractures at different levels of adjustment (n cases/total, 232/1326). Dark line represents HR. Dotted lines represent 95% confidence interval for the HR. Reference value for hip circumference was set at mean hip circumference (101 cm). aTest for curvature P = 0.65, test for overall significance P = 0.003, test for linearity P < 0.001. bTest for curvature P = 0.50, test for overall significance P = 0.55, test for linearity P = 0.39. cTest for curvature P = 0.31, test for overall significance P = 0.29, test for linearity P = 0.24
Fig. 2Hazard ratio (HR) for baseline hip circumference in relation to risk of hip fractures (n cases/total, 257/1452) and fractures at other sites (n cases/total, 331/1421). Models were adjusted for baseline values of age, BMI categories, height, smoking, leisure time physical activity, and hormone replacement therapy. Dark line represents HR. Dotted lines represent 95% confidence interval for the HR. Reference value for hip circumference was set at mean hip circumference (100 cm). aTest for curvature P = 0.49, test for overall significance P = 0.09, test for linearity P < 0.05. bTest for curvature P = 0.07, test for overall significance P = 0.07, test for linearity P = 0.20